Currently used symptomatic drugs for AD treatment, i.e., donepezil and rivastigmine, act as inhibitors of acetylcholinesterase (AChE) and/or butyrylcholinesterase (BuChE) [18]. Here, ACHE is linked to Alzheimer disease.